اكتشف أفضل عيادات وتكاليف العلاج العلاج بـ Lutetium-177 في إسرائيل 2026

Top Lutetium-177 therapy specialists in Israel lead global cancer care. These experts include Prof. Einat Even-Sapir and Dr. Inna Ospovat at Sourasky Medical Center. They specialize in nuclear medicine. Their training includes fellowships at Oxford and leading London hospitals.

• Theranostic approach: Prof. Einat Even-Sapir integrates PET/CT imaging with targeted radionuclide therapy.
• Prostate cancer care: Dr. Meital Levartovsky at Sheba Medical Center focuses on PSMA treatments.
• Neuroendocrine tumors: Dr. Simona Glasberg at Hadassah Medical Center leads specialized PRRT programs.
• Multidisciplinary protocols: Prof. David Sarid combines uro-oncology expertise with advanced radionuclide therapy plans.

Bookimed Expert Insight: Israeli specialists often hold dual expertise in nuclear medicine and oncology. Dr. Simona Glasberg trained at St. Bartholomew's in London. Prof. David Sarid studied at Oxford. This international training helps them design complex therapy protocols. They manage advanced cases across Tel Aviv, Jerusalem, and Haifa centers.

Patient Consensus: Patients mention feeling confident because doctors explain the PET/CT scans clearly. They note the coordination between the imaging and therapy teams is very smooth. Many say the staff made them feel comfortable during the long treatment hours.

Israeli nuclear medicine experts specialize in Lutetium-177 therapy by targeting specific receptors. Prof. Simona Glasberg at Hadassah Medical Center leads neuroendocrine PRRT. Prof. David Sarid at Sourasky Medical Center focuses on prostate PSMA therapy. These doctors work in multidisciplinary teams for precise treatment.

• Neuroendocrine specialists: Prof. Simona Glasberg leads the region's only ENETS center.
• Prostate cancer experts: Prof. David Sarid manages advanced Lutetium-177 PSMA programs.
• Nuclear medicine leaders: Prof. Einat Even-Sapir directs molecular imaging for diagnosis.
• Theranostic centers: Sheba Medical Center combines therapy with high-end imaging.

Bookimed Expert Insight: Israeli specialists often provide a centralized 'theranostic' approach. Prof. Einat Even-Sapir and Prof. Zohar Keidar use Ga-68 PET/CT scans first. This confirms the Lutetium-177 will reach the specific tumor targets. Patients receive both diagnosis and therapy at the same facility.

Patient Consensus: Patients note the coordination between the oncology and nuclear departments is smooth. They felt safer knowing the imaging confirmed the therapy would work. Many were surprised by how quickly they could start treatment.

Leading specialists in Lutetium-177 therapy practice at major Israeli centers like Ichilov and Sheba. These experts hold international certifications in nuclear medicine and uro-oncology. They offer advanced PSMA and PRRT programs. Most specialists trained at top institutions in the UK and USA.

• Tel Aviv Sourasky: Prof. Einat Even-Sapir leads nuclear medicine with Ga-68 PSMA PET/CT expertise.
• Sheba Medical Center: Dr. Meital Levartovsky designs targeted radionuclide protocols for prostate cancer.
• Hadassah Medical Center: Dr. Simona Glasberg provides PRRT care at an ENETS-accredited center.
• Specialized oncology units: Prof. David Sarid manages complex PSMA therapy cases with 35+ years experience.

Bookimed Expert Insight: Israeli specialists often combine genomic profiling with radionuclide therapy for better results. Dr. Ari Raphael at Ichilov integrates target mapping with Lu-177 for individual cases. This approach helps tailor the radiation dose to the patient's specific tumor markers.

Patient Consensus: Patients mention the hospital staff explains the therapy steps very clearly. They feel comfortable having nuclear medicine and oncology experts working together. Many note that the facilities for radiation therapy stay are quiet and modern.